Evidence map›Paper›PMID 38749703›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2024

Dysregulated Cholinergic Signaling Inhibits Oligodendrocyte Maturation Following Demyelination.

Roopa Ravichandar, Farah Gadelkarim, Rupadevi Muthaiah, Nicolas Glynos, Kateryna Murlanova, Nagendra K Rai, Darpan Saraswat, Jessie J Polanco, Ranjan Dutta, Dinesh Pal and 1 more

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Curcumin-Piperine Self-Nanoemulsifying Delivery inPharmaceuticals (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Roopa RavichandarNeuroscience Program, Jacob's School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York 14203.
Farah GadelkarimNeuroscience Program, Jacob's School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York 14203.
Rupadevi MuthaiahDepartment of Pharmacology and Toxicology, Jacob's School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York 14203.
Nicolas GlynosDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan 48109.
Kateryna MurlanovaDepartment of Physiology and Biophysics, Jacob's School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York 14203.
Nagendra K RaiDepartment of Neuroscience, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195.
Darpan SaraswatDepartment of Pharmacology and Toxicology, Jacob's School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York 14203.ORCID 0000-0002-3226-8656
Jessie J PolancoNeuroscience Program, Jacob's School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York 14203.
Ranjan DuttaDepartment of Neuroscience, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195.ORCID 0000-0001-8502-4455
Dinesh PalDepartment of Anesthesiology, University of Michigan, Ann Arbor, Michigan 48109.ORCID 0000-0003-1239-5057
Fraser J SimNeuroscience Program, Jacob's School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York 14203 fjsim@buffalo.edu.ORCID 0000-0002-3942-6637

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Enabling Access to Cutting-Edge Biomedical and Behavioral ScienceR25GM095459 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI DUBOCOVICH, MARGARITA L · 2012 to 2021
$4.4M
Understanding role of circadian disruption in pathogenesis of MSR01NS123532 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI Ranjan Dutta, sujata Rao · 2022 to 2026
$2.2M
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor DifferentiationR01NS104021 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SIM, FRASER JAMES · 2018 to 2022
$1.7M
NCATS NIH HHS UL1 TR001412NIGMS NIH HHS R25 GM095459NINDS NIH HHS R01 NS104021
6 · The paper itself

Abstract

Dysregulation of oligodendrocyte progenitor cell (OPC) recruitment and oligodendrocyte differentiation contribute to failure of remyelination in human demyelinating diseases such as multiple sclerosis (MS). Deletion of muscarinic receptor enhances OPC differentiation and remyelination. However, the role of ligand-dependent signaling versus constitutive receptor activation is unknown. We hypothesized that dysregulated acetylcholine (ACh) release upon demyelination contributes to ligand-mediated activation hindering myelin repair. Following chronic cuprizone (CPZ)-induced demyelination (male and female mice), we observed a 2.5-fold increase in ACh concentration. This increase in ACh concentration could be attributed to increased ACh synthesis or decreased acetylcholinesterase-/butyrylcholinesterase (BChE)-mediated degradation. Using choline acetyltransferase (ChAT) reporter mice, we identified increased ChAT-GFP expression following both lysolecithin and CPZ demyelination. ChAT-GFP expression was upregulated in a subset of injured and uninjured axons following intraspinal lysolecithin-induced demyelination. In CPZ-demyelinated corpus callosum, ChAT-GFP was observed in Gfap

Indexed as

Demyelinating DiseasesOligodendrogliaSignal TransductionAcetylcholineAnimalsCell DifferentiationCholine O-AcetyltransferaseCuprizoneFemaleLysophosphatidylcholinesMaleMiceMice, Inbred C57BLMice, TransgenicMyelin SheathRemyelinationAcetylcholineCholine O-AcetyltransferaseCuprizoneLysophosphatidylcholinesacetylcholinebutyrylcholinesteraseremyelination

Identifiers

PMID38749703
PMCPMC11236584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.